3 Flashcards

1
Q

What does secretin do in relation with bicarbonate?

A

Stimulates its secretion from the pancreatic duct cells and biliary tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What stimulates secretin secretion?

A

Stimuli for release
- Acid in duodenum and jejunum (pH <4.5)
(small amounts can be released fromileum)
- Fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does secritin do in relation to pepsin?

A

Stimulates pepsin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where is GIP released from and what stimulates its release?

A
  • Released from K-cells of duodenum and proximal jejunum
  • All major foodstuffs—fat must be hydrolyzed.
  • Oral glucose but not i.v. glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does GIP stimulate the release of and what does it inhibit?

A

Stimulates the release of insulin and inhibits gastrin (Enterogasrone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are PROGLUCAGON-DERIVED PEPTIDES (GLPGLUCAGON-LIKE PEPTIDES) released from and what stimulates their release?

A

L cells

oral ingestion of Carbohydrates or fats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do PROGLUCAGON-DERIVED PEPTIDES (GLPGLUCAGON-LIKE PEPTIDES) do in relation to insulin and glucagon?

A

Secretion, thus called an incretin hormone
- Suppresses glucagon secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do PROGLUCAGON-DERIVED PEPTIDES (GLP GLUCAGON-LIKE PEPTIDES) do in relation to gastric emptying, food aptite, and beta cell profilation?

A

Slows gastric emptying
- Reducesfood intake via the reduction of appetite
- Promotes beta cell proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does GLP help pateints with Type 2 diabetes?

A

In patients with type 2 diabetes mellitus (T2DM), GLP-1 concentrations are
decreased in response to an oral glucose load. Clinical data have demonstrated
that GLP-1 receptor agonists therapies help restore insulin secretory functions, thus improving glycemic control and reducing body weight in patients with T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the structure of molitin?

A

Linear 22 AA polypeptide - unrelated to other hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly